Search for: "Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp.,"
Results 1 - 9
of 9
Sort by Relevance
|
Sort by Date
5 Oct 2022, 8:12 pm
Merck Sharp & Dohme Corp. [read post]
1 Oct 2022, 2:31 pm
Merck Sharp & Dohme Corp., No. [read post]
8 Dec 2020, 1:00 pm
[1] Complaint at 1-2, Merck Sharp & Dohme Corp. v. [read post]
10 Sep 2018, 10:17 am
Roxane was that Acorda lost:Roxane Laboratories, Inc.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]
21 Nov 2012, 5:00 am
Merck Sharp & Dohme Corp., 807 N.W.2d 343, 347 (Mich. [read post]
30 Jun 2010, 5:52 am
Mylan Pharmaceuticals Inc. et al. [read post]
29 Jun 2010, 6:01 pm
Mylan Pharmaceuticals Inc. et al. [read post]
18 Mar 2010, 2:30 am
(Patent Docs) Atripla (Emtricitabine) - US: District Court S D New York: Patent infringement suit filed following a Paragraph IV Certification: Merck, Sharp & Dohme Corp. et al. v. [read post]
17 Feb 2010, 5:10 am
Merck, Sharp & Dohme Corp. [read post]
